We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
951
CALL
DELISTED
bluebird bio
BLUE
| $165K | ﹤0.01% |
+2,500
| New | +$183K |
|
|
BLUE
952
PUT
DELISTED
bluebird bio
BLUE
| $165K | ﹤0.01% |
+2,500
| New | +$183K |
|
|
FITB
953
Fifth Third Bancorp
FITB
$51.2B
| $160K | ﹤0.01% |
6,100
-40,900
| -87% | -$1.05M |
|
954
BioLife Solutions
BLFS
$1.53B
| $155K | ﹤0.01% |
+7,035
| New | +$148K |
|
|
ESMT
955
DELISTED
EngageSmart, Inc.
ESMT
| $153K | ﹤0.01% |
8,000
| – | – |
|
956
Kopin
KOPN
$652M
| $151K | ﹤0.01% |
+70,000
| New | +$105K |
|
957
PUT
Viatris
VTRS
$20.4B
| $150K | ﹤0.01% |
15,000
| – | – |
|
958
PUT
MacroGenics
MGNX
$235M
| $149K | ﹤0.01% |
27,900
| – | – |
|
|
LLAP
959
CALL
DELISTED
Terran Orbital Corporation
LLAP
| $148K | ﹤0.01% |
+98,900
| New | +$157K |
|
960
Titan Machinery
TITN
$396M
| $148K | ﹤0.01% |
5,000
-3,400
| -40% | -$102K |
|
961
Cognizant
CTSH
$24.9B
| $146K | ﹤0.01% |
2,231
-5,430
| -71% | -$336K |
|
962
US Bancorp
USB
$98.2B
| $144K | ﹤0.01% |
+4,363
| New | +$141K |
|
963
SLB Ltd
SLB
$73.6B
| $142K | ﹤0.01% |
2,881
-4,619
| -62% | -$220K |
|
|
TSP
964
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $141K | ﹤0.01% |
84,877
| – | – |
|
965
BlackBerry
BB
$4.98B
| $138K | ﹤0.01% |
+25,000
| New | +$121K |
|
966
Constellium
CSTM
$3.76B
| $138K | ﹤0.01% |
8,035
| – | – |
|
967
PUT
Rayonier Advanced Materials
RYAM
$604M
| $137K | ﹤0.01% |
+32,000
| New | +$151K |
|
|
VRAY
968
DELISTED
ViewRay, Inc.
VRAY
| $133K | ﹤0.01% |
377,086
-395,914
| -51% | -$410K |
|
|
VISN
969
Vistance Networks Inc
VISN
$2.65B
| $129K | ﹤0.01% |
+22,900
| New | +$109K |
|
|
NNDM
970
Nano Dimension
NNDM
$316M
| $127K | ﹤0.01% |
+43,924
| New | +$109K |
|
971
PUT
Cerus
CERS
$433M
| $123K | ﹤0.01% |
50,000
| – | – |
|
972
Adaptive Biotechnologies
ADPT
$3.59B
| $122K | ﹤0.01% |
+18,200
| New | +$135K |
|
973
CALL
Xeris Biopharma Holdings
XERS
$1.39B
| $116K | ﹤0.01% |
+44,400
| New | +$113K |
|
|
OSG
974
Octave Specialty Group
OSG
$243M
| $114K | ﹤0.01% |
8,000
-7,000
| -47% | -$102K |
|
975
CALL
First Horizon
FHN
$12.2B
| $113K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.